Abstract
Primary malignant melanoma of the urethra is an aggressive neoplasm associated with a poor prognosis. The outcome is dependent on early diagnosis and surgical intervention. However, the diagnosis is often delayed as a result of difficulties related to differentiating this lesion from other disorders. Such difficulties result from the variety of clinical and pathologic presentations that are common to melanoma. We report a case of primary malignant melanoma of the urethra with subsequent retrograde seeding of the bladder initially diagnosed and managed as invasive urothelial carcinoma.
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carcinoma, Transitional Cell / diagnosis*
-
Chemotherapy, Adjuvant
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Cystectomy
-
Diagnostic Errors*
-
Doxorubicin / administration & dosage
-
Humans
-
Lymph Node Excision
-
Male
-
Melanoma / diagnosis*
-
Melanoma / pathology
-
Melanoma / secondary
-
Melanoma / surgery
-
Methotrexate / administration & dosage
-
Neoplasm Invasiveness
-
Neoplasm Seeding
-
Penis / surgery
-
Prostatectomy
-
Urethral Neoplasms / diagnosis*
-
Urethral Neoplasms / drug therapy
-
Urethral Neoplasms / pathology
-
Urethral Neoplasms / surgery
-
Urinary Bladder Neoplasms / etiology
-
Urinary Bladder Neoplasms / secondary
-
Urinary Diversion
-
Vinblastine / administration & dosage
Substances
-
Vinblastine
-
Doxorubicin
-
Cisplatin
-
Methotrexate